Progression from prediabetes to type 2 diabetes mellitus in adolescents: a real world experience

被引:6
|
作者
Weiner, Alyson [1 ]
Zhang, Meng [2 ]
Ren, Sheng [2 ]
Tchang, Beverly [1 ]
Gandica, Rachelle [3 ]
Murillo, Jaime [2 ]
机构
[1] Comprehens Weight Control Ctr, Div Endocrinol Diabet & Metab, Weill Cornell Med, New York, NY 10065 USA
[2] Optum Labs, Eden Prairie, MN USA
[3] Columbia Univ, Irving Med Ctr, Div Pediat Endocrinol Diabet & Metab, New York, NY USA
关键词
prediabetes; adolescents; metformin; type; 2; diabetes; pediatric diabetes care; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; FOLLOW-UP; METFORMIN; YOUTH; CHILDREN; OBESITY; COHORT;
D O I
10.3389/fcdhc.2023.1181729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Obesity in pediatric patients is strongly associated with increased vascular and metabolic risk. Prediabetes is present in up to 1 in 5 adolescents, aged 12-18 years-old, though is thought to remit spontaneously in a significant portion. Pediatric patients with type 2 diabetes mellitus (T2D) have a more rapid decline of beta-cell function and progression to treatment failure than adult T2D patients. Thus, there is a strong interest in better understanding the natural history of prediabetes in these youth. We aimed to evaluate the real-world rate of progression of prediabetes to T2D in adolescent patients.Methods This is a retrospective study of 9,275 adolescent subjects aged 12-21 years-old with at least 3 years of de-identified commercial claims data and a new diagnosis of prediabetes during the observation period. Enrollees with a T2D diagnosis and/or diabetes medication use in the 1 year prior to prediabetes diagnosis or a T2D diagnosis in the 1 month following prediabetes diagnosis were excluded. Enrollees with diagnoses of type 1 diabetes (T1D) or polycystic ovarian syndrome over the 3 years were also excluded. Progression to T2D was defined by claims data of two T2D diagnoses at least 7 days apart, HbA1c >= 6.5%, and/or prescription of insulin without known T1D. Enrollees were followed for 2 years after prediabetes diagnosis.Results Overall, 232 subjects (2.5%) progressed from prediabetes to T2D. There were no differences found in T2D progression based on sex or age. Progression to T2D occurred at a median of 302 days after prediabetes diagnosis (IQR 123 to 518 days). This study was limited by the lack of laboratory/anthropometric data in administrative claims, as well as the exclusion of 23,825 enrollees for lack of continuous commercial claims data over 3 years.Conclusion In the largest sample to date on adolescent prediabetes, we found a 2.5% progression of prediabetes to T2D over a median duration of about one year.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus
    Nagahori, Wataru
    Takenoshita, Hiromasa
    Yuki, Kataoka
    Kimachi, Miho
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (04) : 299 - 299
  • [42] Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus
    Gunderson, Erica P.
    Hurston, Shanta R.
    Ning, Xian
    Lo, Joan C.
    Crites, Yvonne
    Walton, David
    Dewey, Kathryn G.
    Azevedo, Robert A.
    Young, Stephen
    Fox, Gary
    Elmasian, Cathie C.
    Salvador, Nora
    Lum, Michael
    Sternfeld, Barbara
    Quesenberry, Charles P., Jr.
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (12) : 889 - +
  • [43] TYPE 2 DIABETES MELLITUS IN PATIENTS 75 YEARS AND OLDER: FINDINGS FROM A "REAL WORLD" SETTING
    Montano, M. A.
    Feng, A.
    Phillips, K. K.
    Cigolle, C.
    GERONTOLOGIST, 2013, 53 : 483 - 483
  • [44] Association of Plasma Magnesium with Prediabetes and Type 2 Diabetes Mellitus in Adults
    Sijing Chen
    Xiaoling Jin
    Jun Liu
    Taoping Sun
    Manling Xie
    Wei Bao
    Xuefeng Yu
    Xuefeng Yang
    Yan Zhang
    Haibo Zhang
    Zhilei Shan
    Liegang Liu
    Scientific Reports, 7
  • [45] Association of Plasma Magnesium with Prediabetes and Type 2 Diabetes Mellitus in Adults
    Chen, Sijing
    Jin, Xiaoling
    Liu, Jun
    Sun, Taoping
    Xie, Manling
    Bao, Wei
    Yu, Xuefeng
    Yang, Xuefeng
    Zhang, Yan
    Zhang, Haibo
    Shan, Zhilei
    Liu, Liegang
    SCIENTIFIC REPORTS, 2017, 7
  • [46] Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus
    Cusi, Kenneth
    GUT, 2018, 67 (07) : 1371 - 1371
  • [47] TRABECULAR BONE SCORE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND PREDIABETES
    Tsagareli, M.
    Giorgadze, E.
    Zerekidze, T.
    Sulikashvili, T.
    Jeiranashvili, N.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S194 - S194
  • [48] Role of Intermittent Fasting in the Management of Prediabetes and Type 2 Diabetes Mellitus
    Ojo, Tioluwani K.
    Joshua, Olajide O.
    Ogedegbe, Oboseh J.
    Oluwole, Oluwapelumi
    Ademidun, Ayoade
    Jesuyajolu, Damilola
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [49] The risk of hip fractures in patients with type 2 diabetes mellitus and prediabetes
    Kawada, Tomoyuki
    BONE, 2022, 154
  • [50] Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus
    Michael Bergman
    Endocrine, 2013, 43 : 504 - 513